ENDRA Life Sciences
NDRA
8 hedge funds and large institutions have $707K invested in ENDRA Life Sciences in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
60% more funds holding
Funds holding: 5 → 8 (+3)
0% less ownership
Funds ownership: 0% → 0% (-0%)
14% less capital invested
Capital invested by funds: $824K → $707K (-$117K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$29K |
| 2 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
+$29K |
| 3 |
Renaissance Technologies
New York
|
+$29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
ICM Asset Management
Spokane,
Washington
|
-$406K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
NDRA Hedge Fund Activity: Q2 2020 in Review
8 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2020, worth a combined $707K — down 14% from $824K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NDRA positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $29K. The largest seller was ICM Asset Management, cutting an estimated $406K.
- 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2020, up from 5 in Q1 2020.
- Funds reported $707K of ENDRA Life Sciences stock for Q2 2020, down 14% quarter-over-quarter.
- 4 funds opened new ENDRA Life Sciences positions in Q2 2020 and 1 closed out, a net change of +3 holders.
- The largest ENDRA Life Sciences buyer in Q2 2020 was Citadel Advisors, an estimated $29K added.
- The largest ENDRA Life Sciences seller in Q2 2020 was ICM Asset Management, an estimated $406K sold.
Based on aggregated 13F filings for Q2 2020.